Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Smoking and alcohol cessation programs in patients with head and neck cancer].
Hamant C, Deneuve S, Albaret MA, Zrounba P, Breton P, Céruse P, Gleizal A, Alix T, Bettega G, Chauvin F, Saintigny P, Régnier Denois V. Hamant C, et al. Among authors: saintigny p. Bull Cancer. 2018 Nov;105(11):1012-1019. doi: 10.1016/j.bulcan.2018.07.006. Epub 2018 Sep 7. Bull Cancer. 2018. PMID: 30201374 French.
[Contribution and challenges of Big Data in oncology].
Saintigny P, Foy JP, Ferrari A, Cassier P, Viari A, Puisieux A. Saintigny P, et al. Bull Cancer. 2017 Mar;104(3):281-287. doi: 10.1016/j.bulcan.2016.10.020. Epub 2016 Nov 25. Bull Cancer. 2017. PMID: 27894504 Review. French.
Chemotherapy for recurrent/metastatic head and neck cancers.
Karabajakian A, Toussaint P, Neidhardt EM, Paulus V, Saintigny P, Fayette J. Karabajakian A, et al. Among authors: saintigny p. Anticancer Drugs. 2017 Apr;28(4):357-361. doi: 10.1097/CAD.0000000000000473. Anticancer Drugs. 2017. PMID: 28166090 Review.
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
Foy JP, Bertolus C, Michallet MC, Deneuve S, Incitti R, Bendriss-Vermare N, Albaret MA, Ortiz-Cuaran S, Thomas E, Colombe A, Py C, Gadot N, Michot JP, Fayette J, Viari A, Van den Eynde B, Goudot P, Devouassoux-Shisheboran M, Puisieux A, Caux C, Zrounba P, Lantuejoul S, Saintigny P. Foy JP, et al. Among authors: saintigny p. Ann Oncol. 2017 Aug 1;28(8):1934-1941. doi: 10.1093/annonc/mdx210. Ann Oncol. 2017. PMID: 28460011 Free article.
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP, Bazire L, Ortiz-Cuaran S, Deneuve S, Kielbassa J, Thomas E, Viari A, Puisieux A, Goudot P, Bertolus C, Foray N, Kirova Y, Verrelle P, Saintigny P. Foy JP, et al. Among authors: saintigny p. BMC Med. 2017 Sep 1;15(1):165. doi: 10.1186/s12916-017-0929-y. BMC Med. 2017. PMID: 28859688 Free PMC article.
Immunological and classical subtypes of oral premalignant lesions.
Foy JP, Bertolus C, Ortiz-Cuaran S, Albaret MA, Williams WN, Lang W, Destandau S, Souza G, Sohier E, Kielbassa J, Thomas E, Deneuve S, Goudot P, Puisieux A, Viari A, Mao L, Caux C, Lippman SM, Saintigny P. Foy JP, et al. Among authors: saintigny p. Oncoimmunology. 2018 Sep 21;7(12):e1496880. doi: 10.1080/2162402X.2018.1496880. eCollection 2018. Oncoimmunology. 2018. PMID: 30524889 Free PMC article.
139 results